Pentasa and Azulfidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pentasa (mesalamine) and Azulfidine (sulfasalazine). Common drug interactions include hepatitis among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Pentasa and Azulfidine. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Pentasa?

Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.

What is Azulfidine?

Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.



On Jul, 18, 2026

37 people who take Pentasa and Azulfidine together, and have interactions are studied.

Pentasa and Azulfidine drug interactions.

What are the common drug interactions of Pentasa and Azulfidine, by gender? *:

female:

  1. Hepatitis (inflammation of the liver)
  2. Herpes zoster
  3. Hydronephrosis (water inside the kidney)
  4. Hyperpyrexia (extremely high fever)
  5. Hypertension (high blood pressure)
  6. Ileus (a painful obstruction of the ileum or other part of the intestine)
  7. Immunosuppression
  8. Implant infection (infection at implant site)
  9. Injection site pain
  10. Injection site rash

male:

  1. Asthenia (weakness)
  2. Balance disorder
  3. Blood glucose fluctuation
  4. Cardiac failure
  5. Erythema multiforme (a type of hypersensitivity reaction)
  6. Face oedema (swelling of face)
  7. Herpes simplex (herpes simplex is a common viral infection)
  8. Myocarditis (inflammation of heart muscle myocardium)
  9. Pruritus (severe itching of the skin)
  10. Rash erythematous (redness of the skin)

What are the common drug interactions of Pentasa and Azulfidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Haematuria (presence of blood in urine)
  2. Nephritis (inflammation of the nephrons in the kidneys)
  3. Proteinuria (presence of protein in the urine)

10-19:

n/a

20-29:

  1. Platelet count decreased

30-39:

  1. Lymphadenopathy (disease or enlargement of lymph nodes)
  2. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
  3. Osteoporosis (bones weak and more likely to break)
  4. Ovarian cyst (fluid filled sac of the ovary)
  5. Rash pruritic (redness with itching)
  6. Salpingitis (an infection and inflammation in the fallopian tubes)
  7. Shivering
  8. Stress symptoms
  9. Vaginal discharge
  10. Vaginal mycosis (vaginal fungal infection)

40-49:

  1. Cardiac failure
  2. Generalised oedema (swelling all over the body)
  3. Myocarditis (inflammation of heart muscle myocardium)
  4. Troponin i increased

50-59:

  1. Arthralgia (joint pain)
  2. Oedema (fluid collection in tissue)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Ataxia (loss of full control of bodily movements)
  5. Balance disorder
  6. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Dysarthria (speech disorder)
  9. Gait disturbance
  10. Muscular weakness (muscle weakness)

60+:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Gastroenteritis (inflammation of stomach and intestine)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  5. Diarrhoea
  6. Eye pruritus (eye itching)
  7. Headache (pain in head)
  8. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  9. Hepatic steatosis (fatty liver disease)
  10. Impaired healing

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 21.62%
  2. Pain: 7 people, 18.92%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 13.51%
  4. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 10.81%
  5. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 8.11%
  6. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 8.11%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 8.11%
  8. Asthma: 3 people, 8.11%
  9. Blood Glucose Fluctuation: 3 people, 8.11%
  10. Colitis (inflammation of colon): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Pentasa and Azulfidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pentasa and Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pentasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentasa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azulfidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mesalamine and sulfasalazine (the active ingredients of Pentasa and Azulfidine, respectively), and Pentasa and Azulfidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: